Oban BioPharma is developing a novel oral treatment class for Type 2 diabetes and obesity that works across multiple pathways involved in metabolism at once
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
Ticonderoga Strategic Event Fund focuses event-driven opportunities and mispriced situations created by today’s improving M&A landscape
4MINDS has launched the only AI platform that allows companies to build industry specific language models that are private
A precision neuroscience company developing treatments for children with epilepsy, autism, and other severe neurodevelopmental disorders
Ticonderoga Strategic Event Fund focuses event-driven opportunities and mispriced situations created by today’s improving M&A landscape
A precision neuroscience company developing treatments for children with epilepsy, autism, and other severe neurodevelopmental disorders
troCarWash has the potential to shorten operation times, improve outcomes, and reduce costs
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
A revolutionary approach to treating autoimmune disease that’s rooted in precision medicine, rather than broad immunosuppression
troCarWash has the potential to shorten operation times, improve outcomes, and reduce costs